Thorac cardiovasc Surg
DOI: 10.1055/s-0039-1697914
How to do it
Georg Thieme Verlag KG Stuttgart · New York

Intermuscular S-ICD Implantation in Pediatric Patients

Andrea Ferreiro-Marzal*
1  Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
,
Fernando Rodríguez-Serrano*
2  Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, Granada, Spain
3  Biosanitary Research Institute of Granada (ibs.GRANADA), Granada, Spain
,
María Esteban-Molina
1  Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
,
Teresa González-Vargas
1  Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
,
Francesca Perin
4  Pediatric Cardiology Unit, Virgen de las Nieves University Hospital, Granada, Spain
,
1  Department of Cardiovascular Surgery, Virgen de las Nieves University Hospital, Granada, Spain
2  Institute of Biopathology and Regenerative Medicine (IBIMER), University of Granada, Granada, Spain
3  Biosanitary Research Institute of Granada (ibs.GRANADA), Granada, Spain
5  Department of Surgery and its Specialities, Universidad de Granada, Granada, Spain
› Author Affiliations
Further Information

Publication History

20 February 2019

07 August 2019

Publication Date:
20 October 2019 (online)

Abstract

The use of conventional implantable cardioverter-defibrillators (ICDs) in children presents important technical challenges. We present the surgical technique necessary to adapt the subcutaneous ICD (S-ICD) implantation designed for adults, to children, including patients weighing less than 20 kg. The implant procedure implies a two-incision technique and interfascial serratus anterior–latissimus dorsi dissection to accommodate the device. S-ICD implantation was successfully performed in three patients of 19, 28, and 24 kg, respectively, two of them suffered cardiorespiratory arrest. Intermuscular thoracic implantation of S-ICD might represent an effective strategy for primary or secondary prevention of sudden cardiac death in pediatric patients.

* Both authors contributed equally to this work.